Literature DB >> 30692853

What Does Optical Coherence Tomography Offer for Evaluating Physical Disability in Patients with Multiple Sclerosis?

Ziya Ayhan1, Aylin Yaman1.   

Abstract

Visual dysfunction is one of the most common clinical manifestations of multiple sclerosis (MS). For example, optic neuritis is the onset symptom in 20% of patients with MS. Visual pathway impairment presents in most patients with MS, including patients who have not experienced optic neuritis. During the last decade, many clinical trials of MS have included visual outcomes. One tool used in these studies, optical coherence tomography, is a non-contact, noninvasive, high-resolution optical imaging technology that helps segmentation and measurement of specific retinal layers using computerized algorithms. Optical coherence tomography is used in various stages of MS from diagnosis to treatment of the disease. In this review, we summarize the use of optical coherence tomography in MS and study its usefulness for evaluating the physical disabilities of MS patients.

Entities:  

Keywords:  Ganglion cell layer; inner plexiform layer; multiple sclerosis; optical coherence tomography; physical disability; retinal nerve fiber layer

Year:  2018        PMID: 30692853      PMCID: PMC6278624          DOI: 10.29399/npa.23327

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  38 in total

Review 1.  Spectral-domain optical coherence tomography use in macular diseases: a review.

Authors:  Sebastian Wolf; Ute Wolf-Schnurrbusch
Journal:  Ophthalmologica       Date:  2010-05-04       Impact factor: 3.250

Review 2.  Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.

Authors:  Kristin M Galetta; Peter A Calabresi; Elliot M Frohman; Laura J Balcer
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

Review 3.  Optical coherence tomography--a review of the principles and contemporary uses in retinal investigation.

Authors:  D Thomas; G Duguid
Journal:  Eye (Lond)       Date:  2004-06       Impact factor: 3.775

Review 4.  Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.

Authors:  Axel Petzold; Johannes F de Boer; Sven Schippling; Patrik Vermersch; Randy Kardon; Ari Green; Peter A Calabresi; Chris Polman
Journal:  Lancet Neurol       Date:  2010-09       Impact factor: 44.182

5.  Microcystic macular oedema in multiple sclerosis is associated with disease severity.

Authors:  Jeffrey M Gelfand; Rachel Nolan; Daniel M Schwartz; Jennifer Graves; Ari J Green
Journal:  Brain       Date:  2012-04-25       Impact factor: 13.501

6.  Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes.

Authors:  Fiona Costello; William Hodge; Y Irene Pan; Mark Freedman; Christine DeMeulemeester
Journal:  J Neurol Sci       Date:  2009-03-20       Impact factor: 3.181

7.  Ganglion cell loss in relation to visual disability in multiple sclerosis.

Authors:  Scott D Walter; Hiroshi Ishikawa; Kristin M Galetta; Reiko E Sakai; Daniel J Feller; Sam B Henderson; James A Wilson; Maureen G Maguire; Steven L Galetta; Elliot Frohman; Peter A Calabresi; Joel S Schuman; Laura J Balcer
Journal:  Ophthalmology       Date:  2012-02-23       Impact factor: 12.079

8.  Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.

Authors:  Shiv Saidha; Stephanie B Syc; Mary K Durbin; Christopher Eckstein; Jonathan D Oakley; Scott A Meyer; Amy Conger; Teresa C Frohman; Scott Newsome; John N Ratchford; Elliot M Frohman; Peter A Calabresi
Journal:  Mult Scler       Date:  2011-08-24       Impact factor: 6.312

9.  Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis.

Authors:  J Toledo; J Sepulcre; A Salinas-Alaman; A García-Layana; M Murie-Fernandez; B Bejarano; P Villoslada
Journal:  Mult Scler       Date:  2008-06-23       Impact factor: 6.312

10.  Imaging vitreomacular interface abnormalities in the coronal plane by simultaneous combined scanning laser and optical coherence tomography.

Authors:  A M Tammewar; D-U Bartsch; I Kozak; R Rosen; I A Falkenstein; P Garcia; W R Freeman
Journal:  Br J Ophthalmol       Date:  2008-11-19       Impact factor: 4.638

View more
  1 in total

1.  Identification of clusters in multifocal electrophysiology recordings to maximize discriminant capacity (patients vs. control subjects).

Authors:  M Ortiz Del Castillo; B Cordón; E M Sánchez Morla; E Vilades; M J Rodrigo; C Cavaliere; L Boquete; E Garcia-Martin
Journal:  Doc Ophthalmol       Date:  2019-09-19       Impact factor: 2.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.